Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
44.95
+0.16 (0.36%)
At close: Jun 26, 2026, 4:00 PM EDT
44.80
-0.15 (-0.34%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Definium Therapeutics Employees
As of December 31, 2025, Definium Therapeutics had 106 total employees, including 105 full-time and 1 part-time employees. The number of employees increased by 32 or 43.24% compared to the previous year.
Employees
106
Change (1Y)
32
Growth (1Y)
43.24%
Revenue / Employee
n/a
Profits / Employee
-$2,240,972
Market Cap
5.83B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| Travere Therapeutics | 497 |
| CRISPR Therapeutics AG | 393 |
| Celcuity | 155 |
| Edgewise Therapeutics | 154 |
| Tango Therapeutics | 137 |
| Erasca | 103 |
| Dianthus Therapeutics | 92 |
DFTX News
- 12 hours ago - A Breakthrough-Designated Depression Drug Is 86% Through Its Phase 3, With Topline Data Due This Year - PRNewsWire
- 1 day ago - Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters' Option to Purchase Additional Shares - Business Wire
- 1 day ago - Biotech ETF Index Surges 10% After Rebalance - ETF Trends
- 2 days ago - Definium Therapeutics rises 21.8% - TheFly
- 2 days ago - Definium Therapeutics Stock (DFTX) Soars on a Public Offering Pricing After Strong Trial Results - TipRanks
- 2 days ago - Definium Therapeutics rises 17.7% - TheFly
- 2 days ago - Definium Therapeutics 20.6M share Secondary priced at $34.00 - TheFly
- 2 days ago - Definium Therapeutics price target raised to $74 from $61 at JonesResearch - TheFly